Genetic characterization of acquired aplastic anemia by targeted sequencing

Haematologica

Volumn 99, Issue 9, 2014, Pages

  Heuser, Michael ^a   Schlarmann, Carola ^a   Dobbernack, Vera ^a   Panagiota, Victoria ^a   Wiehlmann, Lutz ^a   Walter, Carolin ^b   Beier, Fabian ^c   Ziegler, Patrick ^c   Yun, Haiyang ^a   Kade, Sofia ^a   Kirchner, Aylin ^a   Huang, Liu ^a,d   Koenecke, Christian ^a   Eder, Matthias ^a   Brümmendorf, Tim H ^c   Dugas, Martin ^b   Ganser, Arnold ^a   Thol, Felicitas ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b UNIVERSITY OF MÜNSTER   (Germany)

^c RWTH AACHEN UNIVERSITY   (Germany)

^d HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

Aplastic anemia; MDS related mutations

Indexed keywords

CYCLOPHOSPHAMIDE; CYCLOSPORIN A; THYMOCYTE ANTIBODY; ANTINEOPLASTIC AGENT; ASXL1 PROTEIN, HUMAN; CARRIER PROTEIN; CELL CYCLE PROTEIN; DNA BINDING PROTEIN; MYBL2 PROTEIN, HUMAN; NERVE PROTEIN; NUCLEAR PROTEIN; ONCOPROTEIN; REPRESSOR PROTEIN; SETBP1 PROTEIN, HUMAN; SLIT1 PROTEIN, HUMAN; TET2 PROTEIN, HUMAN; TRANSACTIVATOR PROTEIN;

ADULT; AGED; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; AMINO ACID SEQUENCE; APLASTIC ANEMIA; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOGENETICS; FEMALE; FOLLOW UP; GENE MUTATION; GENE SEQUENCE; HUMAN; LETTER; MALE; ADOLESCENT; ANEMIA, APLASTIC; COMPLICATION; DNA SEQUENCE; GENETICS; MIDDLE AGED; MUTATION; MYELODYSPLASTIC SYNDROMES; PATHOLOGY; SEVERITY OF ILLNESS INDEX; TELOMERE; TELOMERE HOMEOSTASIS;

ADOLESCENT; ADULT; AGED; ANEMIA, APLASTIC; ANTINEOPLASTIC AGENTS; CARRIER PROTEINS; CELL CYCLE PROTEINS; CHILD; DNA-BINDING PROTEINS; FEMALE; HUMANS; MALE; MIDDLE AGED; MUTATION; MYELODYSPLASTIC SYNDROMES; NERVE TISSUE PROTEINS; NUCLEAR PROTEINS; PROTO-ONCOGENE PROTEINS; REPRESSOR PROTEINS; SEQUENCE ANALYSIS, DNA; SEVERITY OF ILLNESS INDEX; TELOMERE; TELOMERE HOMEOSTASIS; TRANS-ACTIVATORS;

EID: 84907343777     PISSN: 03906078     EISSN: 15928721     Source Type: Journal    
DOI: 10.3324/haematol.2013.101642     Document Type: Letter

References (17)

1. Socie G, Henry-Amar M, Bacigalupo A, Hows J, Tichelli A, Ljungman P, et al. Malignant tumors occurring after treatment of aplastic anemia. European Bone Marrow Transplantation-Severe Aplastic Anaemia Working Party. N Engl J Med. 1993;329(16): 1152-1157.
2. Tichelli A, Schrezenmeier H, Socie G, Marsh J, Bacigalupo A, Duhrsen U, et al. A randomized controlled study in patients with newly diagnosed severe aplastic anemia receiving antithymocyte globulin (ATG), cyclosporine, with or without G-CSF: a study of the SAA Working Party of the European Group for Blood and Marrow Transplantation. Blood. 2011;117(17):4434-4441.
3. Scheinberg P, Young NS. How I treat acquired aplastic anemia. Blood. 2012;120(6):1185-1196.
4. Afable MG 2nd, Wlodarski M, Makishima H, Shaik M, Sekeres MA, Tiu RV, et al. SNP array-based karyotyping: differences and similarities between aplastic anemia and hypocellular myelodysplastic syndromes. Blood. 2013;117(25):6876-6884.
5. Walter MJ, Shen D, Shao J, Ding L, White BS, Kandoth C, et al. Clonal diversity of recurrently mutated genes in myelodysplastic syndromes. Leukemia. 2013;27(6):1275-1282.
6. Adzhubei IA, Schmidt S, Peshkin L, Ramensky VE, Gerasimova A, Bork P, et al. A method and server for predicting damaging missense mutations. Nat Methods. 2010;7(4):248-249.
7. Thol F, Friesen I, Damm F, Yun H, Weissinger EM, Krauter J, et al. Prognostic significance of ASXL1 mutations in patients with myelodysplastic syndromes. J Clin Oncol. 2011;29(18):2499-2506.
8. Langemeijer SM, Kuiper RP, Berends M, Knops R, Aslanyan MG, Massop M, et al. Acquired mutations in TET2 are common in myelodysplastic syndromes. Nat Genet. 2009;41(7):838-842.
9. Lane AA, Odejide O, Kopp N, Kim S, Yoda A, Erlich R, et al. Low frequency clonal mutations recoverable by deep sequencing in patients with aplastic anemia. Leukemia. 2013;27(4):968-971.
10. Thol F, Suchanek KJ, Koenecke C, Stadler M, Platzbecker U, Thiede C, et al. SETBP1 mutation analysis in 944 patients with MDS and AML. Leukemia. 2013;27(10):2072-2075.
11. Meggendorfer M, Bacher U, Alpermann T, Haferlach C, Kern W, Gambacorti-Passerini C, et al. SETBP1 mutations occur in 9% of MDS/MPN and in 4% of MPN cases and are strongly associated with atypical CML, monosomy 7, isochromosome i(17)(q10), ASXL1 and CBL mutations. Leukemia. 2013;27(9):852-860.
12. Heinrichs S, Conover LF, Bueso-Ramos CE, Kilpivaara O, Stevenson K, Neuberg D, et al. MYBL2 is a sub-haploinsufficient tumor suppressor gene in myeloid malignancy. Elife. 2013;2:e00825.
13. Clarke M, Dumon S, Ward C, Jager R, Freeman S, Dawood B, et al. MYBL2 haploinsufficiency increases susceptibility to age-related haematopoietic neoplasia. Leukemia. 2013;27(3):661-670.
14. Saito C, Hosokawa K, Katagiri T, Kanai A, Matsui H, Inaba T, et al. SLIT1 Mutation in Patients with Acquired Aplastic Anemia: Its Relevance in Immune Pathophysiology Blood, Annual Meeting Abstracts. 2012;120(21):#645.
15. Dunwell TL, Dickinson RE, Stankovic T, Dallol A, Weston V, Austen B, et al. Frequent epigenetic inactivation of the SLIT2 gene in chronic and acute lymphocytic leukemia. Epigenetics. 2009;4(4):265-269.
16. Dasouki MJ, Rafi SK, Olm-Shipman AJ, Wilson NR, Abhyankar S, Ganter B, et al. Exome sequencing reveals a thrombopoietin ligand mutation in a Micronesian family with autosomal recessive aplastic anemia. Blood. 2013;122(20):3440-3449.
17. Walne AJ, Dokal A, Plagnol V, Beswick R, Kirwan M, de la Fuente J, et al. Exome sequencing identifies MPL as a causative gene in familial aplastic anemia. Haematologica. 2012;97(4):524-528.